Legaard, Grit E.
Lyngbæk, Mark P. P. https://orcid.org/0000-0002-1931-9658
Almdal, Thomas P. https://orcid.org/0000-0002-7296-4656
Karstoft, Kristian https://orcid.org/0000-0002-6596-4199
Bennetsen, Sebastian L. https://orcid.org/0000-0002-3554-8565
Feineis, Camilla S.
Nielsen, Nina S. https://orcid.org/0000-0001-6564-4278
Durrer, Cody G.
Liebetrau, Benedikte https://orcid.org/0009-0003-3673-5770
Nystrup, Ulrikke
Østergaard, Martin
Thomsen, Katja https://orcid.org/0000-0001-9613-9573
Trinh, Beckey https://orcid.org/0000-0003-2784-7079
Solomon, Thomas P. J. https://orcid.org/0000-0002-0579-284X
Van Hall, Gerrit
Brønd, Jan Christian https://orcid.org/0000-0001-6718-3022
Holst, Jens J. https://orcid.org/0000-0001-6853-3805
Hartmann, Bolette
Christensen, Robin https://orcid.org/0000-0002-6600-0631
Pedersen, Bente K. https://orcid.org/0000-0001-6508-6288
Ried-Larsen, Mathias https://orcid.org/0000-0002-8388-5291
Funding for this research was provided by:
TrygFonden (101390, 20045, 125132)
Svend Andersen Fonden
Oak Foundation
Danish Diabetes Academy
Article History
Received: 18 January 2023
Accepted: 4 April 2023
First Online: 1 May 2023
Competing interests
: J.J.H. is a member of advisory boards for Novo Nordisk. All other authors declare that they have no competing interests.